Singapore, July 25 -- Israel headquarteredScopio Labs, developer of Full-Field Cell Morphology imaging and analysis platform, has announced the unveiling of its groundbreaking Complete Blood Morphology (CBM(R)) analyser.

CBM will bring unprecedented scale, efficiency and standardisation to hematology through autonomous morphology analysis and reporting, one of the last remaining manual processes in diagnostics.

To expedite the go-to-market of CBM(R), Viola Growth has joined as a new investor with a$10 millionextension to Scopio's Series D funding, bringing the total to$52 million.

CBM(R)is built on top of Scopio's proprietary Full-Field technology, leveraging advanced computational imaging and AI-powered analysis to transform current P...